German China India

Pumps in the Pharmceutical Industry

Up to the GMP–Challenge with AODD Pumps

| Author / Editor: Peter Schüten* / Dominik Stephan

Wim Ekkelkamp, Technical Manager, at Ofichem’s API-manufacturing facility and Remco Vree Egberts, right, R&D Manager and Project Leader have chosen the Almatec E-Series Air-Operated Double-Diaphragm Pump because of its Atex certification for handling dangerous materials.
Wim Ekkelkamp, Technical Manager, at Ofichem’s API-manufacturing facility and Remco Vree Egberts, right, R&D Manager and Project Leader have chosen the Almatec E-Series Air-Operated Double-Diaphragm Pump because of its Atex certification for handling dangerous materials. (Source: Almatec)

Related Companies

How pumps help meeting the most stringent Good Manufacturing Practice Guidelines — When you’re working at the highest standards, your process equipment should be up the task. Special care has to given to process euqipment like pumps, when handling hazardous materials in demanding API production environments. Manufacturers need a technology that is 100 % reliable, safe and efficient. A technology like AODD pumps …

The story of Lab Ofichem is an interesting example of how the movements of a highly regulated market can change the face of a company. Originally founded as “Laboratorium Oldenziel Fine Chemicals” in 1975, the company established itself as a successful family-operated developer, manufacturer and distributor of active pharmaceutical ingredients (API) for human and veterinary-medicine markets over the next few decades.

That began to change in the late 1990s when Europe and North America began mandating to incorporate Good Manufacturing Practices (GMP) in their operations, meaning they had to define how and under what conditions a product was manufactured.

While an admirable goal, the required use of GMPs had unintended consequences for many API producers, namely higher production and equipment costs, enabling India and China — which were not subject to the mandates of GMPs — to intrude on the global market.

Going Global

So, in 2006, founder Dr. O.H. Oldenziel made the decision to introduce the GMP guidelines into Ofichem’s operations. Oldenziel never got a chance to see the full blossoming of his vision, as he passed away in December 2006, but his legacy of innovation at Lab Ofichem, now part of a larger umbrella company (along with subsidiaries Ofipharma and Indopharm) known as the Ofichem Group, continues in both execution and name, as his and his wife and co–founder’s son, Weite Oldenziel, is now the group's General Director.

“In combining the knowledge of Lab Ofichem with the network of Ofichem and Indopharm we can help our customers more specifically with their questions and problems,” said Oldenziel. “We can also produce and analyze APIs, and have the facilities to be able to store a large amount of APIs in our own warehouse. In short, we have laid the foundation for a company that is ready for the future.”

That future already includes a global reach, with the Ofichem Group operating satellite sales offices in Barcelona, Spain; Hamburg, Germany; and Paris, France, while it having two offices in China, where a lot of product research and development is performed.

Comments are being loaded ....

Leave a comment

The comment is checked by an editor and will be released soon.

  1. Avatar
    Avatar
    Edited by at
    Edited by at
    1. Avatar
      Avatar
      Edited by at
      Edited by at

Comments are being loaded ....

Report comment

Kommentar Freigeben

Der untenstehende Text wird an den Kommentator gesendet, falls dieser eine Email-hinterlegt hat.

Freigabe entfernen

Der untenstehende Text wird an den Kommentator gesendet, falls dieser eine Email-hinterlegt hat.

copyright

This article is protected by copyright. You want to use it for your own purpose? Contact us via: support.vogel.de/ (ID: 44162089 / Pharma & Food)